Cochlear (ASX: COH) Share Price

COH

$112.97▼-4.38%

$7.39BRank #101 on ASXHealthcareMedical - Devices

Prices updated 23 June 2026, 8:40 am AEST · Data: Financial Modeling Prep

Market Cap

$7.39B

Volume

663K

P/E Ratio

26.4

EPS

$2.4687

Dividend Yield

0.82%

52-Week High

$319.56

52-Week Low

$88.74

Beta

0.252

Cochlear (ASX: COH) is an Australian-listed company in the Healthcare sector with a market capitalisation of $7.39B and the 101st-largest security on the ASX by market capitalisation. The COH share price is $112.97, down 4.38% today and down 60.13% over the past 12 months. Shares have traded between $88.74 and $319.56 over the past 52 weeks. COH trades on a price-to-earnings ratio of 26.40, above the Healthcare sector median of 14.96, and pays a trailing dividend yield of 0.82%. In its most recent reported period (ending 31 Dec 2025), Cochlear reported revenue of $1.18B and a net profit of $161.5M (13.7% margin).

Charts

$113.12

24H Range

$111.87

$118.77

52-Week Range

$88.74

$319.56

About Cochlear Limited

Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.

IPO Date

31 Dec 1995

CEO

Diggory William Howitt

Employees

4,996

Website

cochlear.com

Key Financial Data

Revenue (Quarterly)	$1.18B
Net Income (Quarterly)	$161.5M
Total Assets	$2.79B
Total Debt	$427.8M
Free Cash Flow	$108.8M
Return on Equity	8.33%
Profit Margin	13.73%
Operating Margin	18.78%

COH Frequently Asked Questions

What is the Cochlear (ASX: COH) share price?

The COH share price is $112.97, down 4.38% for the day, based on the latest available ASX market data.

What is Cochlear's market capitalisation?

Cochlear has a market capitalisation of $7.39B, making it the 101st-largest security listed on the ASX.

Does Cochlear pay a dividend?

Yes. COH has a trailing dividend yield of 0.82%.

What is COH's P/E ratio?

Cochlear trades on a trailing price-to-earnings (P/E) ratio of 26.40, based on its current share price and most recent reported earnings.

Is Cochlear profitable?

Yes. In its most recent reported period (ending 31 Dec 2025), COH reported revenue of $1.18B and a net profit of $161.5M.

How many COH shares are on issue?

Cochlear has approximately 65,398,917 shares on issue, based on its market capitalisation of $7.39B and current share price.

What sector is Cochlear in?

Cochlear is classified in the Healthcare sector, within the Medical - Devices industry on the ASX.

When did Cochlear list on the ASX?

Cochlear listed on the Australian Securities Exchange on 31 Dec 1995.

Latest News

Is Cochlear (ASX:COH) Stock Recovering From Earlier Weakness?

Kalkine19 June 2026

Is Cochlear (ASX:COH) Stock Recovering From Earlier Weakness? Kalkine

Cochlear (ASX:COH) drops 4.4% in Sydney as shorts increase

Bez Kabli22 June 2026

Cochlear (ASX:COH) drops 4.4% in Sydney as shorts increase Bez Kabli

At under $100 each, Cochlear shares look like a bargain: Here’s why

The Motley Fool Australia27 May 2026

At under $100 each, Cochlear shares look like a bargain: Here’s why The Motley Fool Australia